News Headlines Article

Clinical Trial for Lymphoma Treatment Called a Success
New York Times

A last-ditch treatment for Hodgkin lymphoma has succeeded in a clinical trial, the drug’s developer, Seattle Genetics, announced Monday.

The company said in a statement that the drug had reduced tumor burden in 75 percent of patients whose cancer was not controlled by chemotherapy and an autologous stem cell transplant.